Logo image
Targeting Wnt Signaling in Endometrial Cancer
Journal article   Open access   Peer reviewed

Targeting Wnt Signaling in Endometrial Cancer

Iram Fatima, Susmita Barman, Rajani Rai, Kristina W. Thiel and Vishal Chandra
Cancers, Vol.13(10), p.2351
05/13/2021
DOI: 10.3390/cancers13102351
PMCID: PMC8152465
PMID: 34068065
url
https://doi.org/10.3390/cancers13102351View
Published (Version of record) Open Access

Abstract

This review presents new findings on Wnt signaling in endometrial carcinoma and implications for possible future treatments. The Wnt proteins are essential mediators in cell signaling during vertebrate embryo development. Recent biochemical and genetic studies have provided significant insight into Wnt signaling, in particular in cell cycle regulation, inflammation, and cancer. The role of Wnt signaling is well established in gastrointestinal and breast cancers, but its function in gynecologic cancers, especially in endometrial cancers, has not been well elucidated. Development of a subset of endometrial carcinomas has been attributed to activation of the APC/beta-catenin signaling pathway (due to beta-catenin mutations) and downregulation of Wnt antagonists by epigenetic silencing. The Wnt pathway also appears to be linked to estrogen and progesterone, and new findings implicate it in mTOR and Hedgehog signaling. Therapeutic interference of Wnt signaling remains a significant challenge. Herein, we discuss the Wnt-activating mechanisms in endometrial cancer and review the current advances and challenges in drug discovery.
Life Sciences & Biomedicine Oncology Science & Technology

Details

Metrics

Logo image